Roche Holding AG (OTCMKTS: RHHBY) was upgraded by analysts at Sanford C. Bernstein to a "strong-buy" rating.
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- 3 High-Yield Dividend ETFs to Buy With $500 and Hold Forever [Yahoo! Finance]Yahoo! Finance
- Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025 [Yahoo! Finance]Yahoo! Finance
- NRG Oncology and Flatiron Health announce collaboration to leverage leading technology to drive more efficient clinical trialsBusiness Wire
- Roche abandons global diversity targets on concern over U.S. executive orders [CNBC]CNBC
- Roche abandons global diversity targets on concern over U.S. executive orders [Yahoo! Finance Canada]Yahoo! Finance Canada